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INTRODUCTION 
Many changes occur during the normal pregnancy 
including changes in the immune system and 
metabolism which is described as the metabolic 
syndrome.1 Gestational Diabetes Mellitus (GDM), a 
condition in which there is a high serum glucose level 
present during the gestation period, is considered as 
a most common metabolic complication during 
pregnancy.2 It usually appears during3 the 29–33 
gestational weeks4 of the second stage of pregnancy, 
and disappears in the postpartum stage.5  In some 
cases, the high blood glucose continues after delivery6 
which may contribute type 1, or type 2 of diabetes.7  
  
In addition, the maternal insulin resistance is 
associated with immediate and long term metabolic 
complications on both maternal and fetal. For 
example, the Gestational Diabetes Mellitus (GDM) is 
responsible for verity of inflammation through the 
gestation period.8 Also, GDM is linked with many 
pregnancy adverse complications outcome, such as 
pre-eclampsia and abnormal delivery.9 Recent studies 
showed that the women who experienced GDM are 
more likely by six times to develop diabetes of type 2, 
as compared with women who had normal blood 
glucose level during the pregnancy period.10-11 Other 
maternal metabolic complications include but do not 
limited hypertension, pre-eclampsia, caesarean 
section,  infection,  and  polyhydramnios.12  Moreover, 
Gestational Diabetes Mellitus (GDM) may be 
associated with new-borns morbidity including 
macrosomia,      birth       trauma,         hypoglycaemia,  
 
 
 
hypercalcemia, hypomagnesemia, 
hyperbilirubinemia, respiratory distress syndrome, 
polycythaemia.13 Also, other studies showed that the 
children of women with GDM are more likely to 
develop obesity or diabetes in childhood or in 
adulthood.12,14-15 
   
Worldwide, the prevalence proportion of the 
Gestational Diabetes during pregnancy rose sharply16-
17, and it ranged between 1% to 14% of all 
pregnancies.18 This variation in prevalence is due to 
genetic, ethnic, demographic, socio-cultural, and 
economic factors.16  A number of common factors 
have been accounted as main contributors of GDM 
including older ages pregnancy, obesity, family 
history of diabetes (FHD), previous history of GDM, 
congenital malformation, and caesarean section.19-23 
Other controversial causes include smoking history, 
physical inactivity, and socioeconomic factors.9,19,20,24 
On the other hand, diet is playing a major role in 
determining the health status of individuals.25 In the 
past few decades, many studies showed that the 
incidence of gastrointestinal tract problems, such as 
bloating, flatulence, constipation, diarrhea, 
inflammation, and damage of the gut lining have 
been increasing sharply.26 Also, the dietary pattern of 
women before and during pregnancy is correlated 
with  developing  many health adverse effects, such as 
he Gestational Diabetes Mellitus (GDM)27 with the 
pregnancy outcome.28-29 Thus, the relation between  
diet and health has been  considered as an interesting  
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topic for many individuals who increased the demand 
after the health information related to the healthier 
food diet.30  
 
In the recent years, probiotics have been presented as 
a novel therapy for controlling high glucose level 
during pregnancy31-32 and improve the maternal 
metabolism and pregnancy outcome.33 This review 
was done based on Randomized Control Studies 
(RCT) to investigate the efficiency of the Gut 
microbiota such as probiotics in controlling the blood 
glucose level and improve maternal metabolism and 
pregnancy outcome. A systematic computer search of 
the databases from MEDLINE, LISTA, PubMed, Web 
of science, CINAHL.   
 
1. Gut microbiota and diabetes  
The human digestive tract is considered as a place for 
a large community of microorganisms (Gut flora, gut 
microbiota or gastrointestinal microbiota) that have a 
direct influence on the human34 and non-human 
health.35 The human gut microbiotas have been 
shaped through multi-factors during the infancy 
period34 including diet such as, breast milk vs. 
formula feeding, antibiotic usage,36 and the diet 
pattern has been considered as the main contributory 
factor in forming the gastrointestinal microbiota.37 
Recent studies indicated that the bacterial gut has a 
pivotal role in protecting the body against illness and 
infections, keep metabolic homeostasis, immune 
tolerance38, and modulation of the intestinal 
epithelium.39   
 
In relation to this, the nutritional attitude plays a 
significant role in modelling the gut microbiomes.40 
The high fat and fructose diet have been determined 
as main contributors of alteration of the normal gut 
microflora (dysbiosis)40 which may be linked to the 
pathogenesis of many illnesses and health disability 
(41, 42) such as, Diabetes Mellitus (DM),43 and 
Gestational Diabetes Mellitus (GDM) (44). Hence, the 
gut microbial data may be a novel source of assessing 
lifestyle and the food diet quality score of human and 
non-human being40,45 and set an effective promotion 
plan to manage diseases related to the imbalance of 
the bacterial gut.40  
 
On the other hand, various metagenomic studies on 
humans and animals, have been done to validate the  
influence of the gastrointestinal microbiota on the 
body mass index (BMI) and in developing diabetes.46 
After weight gain, human studies showed that some 
strains of the gut microbiota increased while other 
strains decreased or remained neutral.47-49 For 
example, in 2010, a study was done to investigate the 
composition changes of the human gut microbiota 
among individuals with type 2 diabetes.50 The study 
indicated that unhealthy dietary intake may lead to 
the imbalance of the gut bacteria. The V4 region of 
the 16S rRNA gene was analyzed by tag-encoded 
amplicon pyrosequencing, and showed the decreased 
proportion of phylum Firmicutes and Clostridia while 
increased proportions of Betaproteobacteria and 
increased ratios of Bacteroidetes to Firmicutes and 
Bacteroides– Prevotella group to Clostridium 
coccoides– Eubacterium rectale which showed a 
significant correlation with high plasma glucose 
concentration.50 The mice model studies showed that 
the mice with a high-fat diet (HFD) had an insulin 
resistance as a consequence of the change in the 
composition of bifidobacteria and lactobacilli bacteria 
group.51-52 The plasma lipopolysaccharides level (LPS) 
was increased as a result of decreased proportion of 
Bifidobacterium and Lactobacillus which led to 
metabolic endotoxemia.51-53 
  
The proportion alteration in the gut microbiota 
strains lead to changing in the gut hormone 
secretions (like glucose-dependent insulinotropic 
peptide, GLP-1, GLP-2, PYY) which directly affect B-
cell’s mass and function, energy intake, nutrients 
absorption and energy storage as well as insulin 
secretion as a consequence of changing the 
enteroendocrine signals.40 Also, other studies 
indicated that the alteration of the gut flora is linked 
with bile acid pool and biosynthetic pathway as a 
consequence of the alteration in the enteroendocrine 
signals in the diabetic patients.54  
 
Despite the changing of the gut bacterial 
composition, it may be linked with many health 
adverse effect, there is an evidential support, in a 
clinical practice, that modifying the gut microbiota 
helps regulate the blood glucose level effectively (55). 
In this context, modelling the gut flora by prebiotics 
diet has been presented as an effective prevention 
through enhanced host-gut bacterial interaction 
against obesity and overweight and metabolic 
diseases.56-60 
  
2. Managing the Gestational Diabetes Mellitus 
(GDM) by diet.  
There is a multi-directional relationship between 
diet, host metabolism, and gut microbiome (different 
strains of bacteria in the gut).61 The diet can directly 
influence the microbiome composition.61 Thus, any 
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altering in the gut microbiome composition may 
influence the host metabolism including nutrient 
absorption62, and effect the glucose, lipid metabolism 
and the inflammatory pathway of the host.63-64   
 
Recent theories argued that the gut microorganisms 
(Probiotics) play an essential role in managing the 
GDM32 through improving body metabolism as a 
consequence of improving the digestion and 
absorbing the lactose and other nutrients.65 
Therefore, The maternal complications during 
pregnancy such as Gestational Diabetes Mellitus 
(GDM) may be managed through improving the diet 
choices of  pregnant women.66   
  
2.1. Prebiotics diet as a primary prevention 
choice against chronic diseases   
Prebiotics are considered as an essential non-
digestible nutritive substance.67 It enhances the 
microorganism (probiotics) in the large intestinal 
tract68 to growth, activity, and metabolism.69-71 The 
term prebiotic had been defined previously as, “The 
selective stimulation of growth and/or activity of one 
or a limited number of microbial genus/species in the 
gut microbiota that confer health benefits to the 
host”.72 The recent definition of prebiotic by the 
International Scientific Association for Probiotics and 
Prebiotics (ISAPP) is, “A substrate that is selectively 
utilized by host microorganisms conferring a health 
benefit”.73 As the number of food ingredients and 
dietary fibers classified as prebiotic increases, the 
following criteria for classification must be 
established: “(i) resistance to gastric acidity, 
hydrolysis by mammalian enzymes, and 
gastrointestinal absorption; (ii) fermentation by 
intestinal microbiota; (iii) selective stimulation of the 
growth and/or activity of intestinal bacteria 
associated with health and well-being”.74 The 
Prebiotics food group consist of variant food groups 
including (but do not limit) Insulin (yogurts, dairy 
desserts, cheeses, ice cream, and baked products), 
Fructo-oligosaccharides (Baby food, yogurts, bread, 
baked products), and Galacto-oligosaccharides 
(yogurts, fruit juice).75 The symbiosis of the probiotics 
with the host, predominantly in our gastrointestinal 
tract (GI), has been scientifically proven to be 
important for our health and well-being. For 
example, it optimizes the process of food digestion76 
and consumption.77 Additionally, the main function 
of prebiotics is to increase carbohydrate metabolism 
and trigger bacterial growth that is beneficial to the 
intestinal microflora.78  The   increasing  popularity of  
probiotics and prebiotics have been due to current 
research that suggests the positive effect on various 
health conditions including (but do not limit) to 
gastrointestinal transit time, irritable bowel 
syndrome and ulcerative colitis.79 Aside from the 
benefits to the gastrointestinal tract, further 
beneficial health effects include immune stimulation, 
reduction in blood lipid levels, effects upon insulin 
resistance, metabolites that influence brain function, 
energy and cognition, and mineral bioavailability in 
the bone among others.73 
   
On the other hand, Prebiotics could soon be a tool to 
combat overweight and obesity.80 A recent study by 
Nicolucci et.al. (2017), showed the effect of the 
prebiotic, oligofructose-encriched inulin, alter the 
intestinal microbiota and significantly reduce the 
body weight z-score, percent body fat, percent trunk 
fat, and serum level of interleukin in children with 
obesity.81   
  
Another research shows that prebiotics that 
enhanced the growth of bacteria, which were short-
chain fatty-acids (SCFA) producers, have been 
beneficial in the management of metabolic syndrome 
(MetS) components such as abdominal obesity, low-
grade chronic systemic inflammation, altered glucose 
metabolism, dyslipidaemia, and high blood pressure. 
These beneficial bacteria have protective effects and 
have shown to improve metabolic syndrome 
components especially for individuals with Type 2 
diabetes.82 Also, a study by Deghan et al., (2015), 
discussed the impact of prebiotic supplementation to 
patients with type 2 Diabetes Mellitus. Previously, 
physical inactivity and obesity were usually attributed 
to the cause of the disease. It has been recently 
suggested that changes in gut microflora is a factor in 
the development of the type 2 diabetes. The result of 
the study showed that the oligofructose-enriched 
insulin had improved the glycaemic status, lipid 
profile and immune markers of the diabetic 
patients.83  Furthermore, studies have been made on 
the effects of prebiotics on pregnancy health. Sohn 
and Underwood (2017) discussed the benefit of 
administering prebiotics and probiotics to pregnant 
women. Dysbiosis during pregnancy increases the 
risk of pre-eclampsia, diabetes, infection, preterm 
labor, and later childhood atopy. Administration of 
prebiotics and probiotics during pregnancy, lactation 
and post-natal offer a safe treatment to improve 
pregnancy and neonatal outcomes.84 Also, many 
studies   indicated   that   managing and treatment  of  
101 
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GDM by diet, with or without medication  
pills,reducethe pregnancy and maternity 
complications and improve the pregnancy outcome.61 
  
2.2. Probiotics properties and benefits    
The probiotics were presented in 1960 by a Russian 
biologist, Elie Metchnikoff.85 He hypothesized that 
there are harmful chemicals produced by the human 
gut as an unintended consequence of digestion, and 
these chemicals may lead to health complications 
including aging, infection, and illness.85 Additionally, 
Elie Metchnikoff suggested that eating “Acid-
producing bacteria diet” may help to eliminate the 
harmful chemicals which may improve the 
individual’s overall health.85 
   
Probiotics strains (helpful bacteria) have been 
considered as intestinal microorganisms that can 
improve the host health condition33 through many 
mechanisms86 including modification of the gut 
microbiota (microflora), competitive adherence to 
the mucosa and epithelium, strengthening of the gut 
epithelial barrier and modification of the immune 
system to enhance the overall health of the host.87 
  
Recently, scientists confirmed that there are specific 
probiotics bacterial strains in the gut which have the 
ability to eliminate the toxicity by modifying the flora 
and replacing the harmful bacterial with good 
(useful) ones.85  According to the probiotics strain, 
the efficacy research’s, Vitro, vivo, genetic and omics 
indicated that the probiotics strains may have various 
effect on our overall health.88 For example, strains of 
Probiotics, particularly lactobacilli and 
bifidobacterial, have been confirmed as an effective 
dietary intervention to manage intestinal illness, and 
life- style metabolic problems,40 especially in 
humans89, while other studies confirmed the 
beneficial effect of the muciniphila MucT (Probiotics 
strain) on glucose metabolism in mouse model.90  
  
In the recent years, studies about the health benefits 
of probiotics in our intestinal microbial ecology and 
immunity have significantly increased.91 The relation 
between human’s dietary habits and gut microbiota 
metabolism, and its effect on our health is being 
studied progressively.92 There has been studies about 
the gut microbiota as a possible therapeutic 
treatment for obesity due to its importance in 
processing dietary polysaccharides, which affects the 
energy yield from the diet and energy metabolism in 
the host.63 This increased knowledge of the functional 
connections between the complex microbial 
community, metabolism, and host could lead to 
treatment of metabolic syndromes including (but do 
not limit) to Type 2 diabetes.93  
  
Also, in 2015, a result of a meta-analysis study showed 
that consumption of probiotic can play a major effect 
on glycemic control94, so it has been considered as a 
novel strategy to void progression and development 
of diabetes as a consequence of improving the 
modification of the gut microbial composition.40 
  
2.3. Probiotic efficacy in animal models against 
diabetes   
Broadly, the mechanisms of the gut flora have been 
studied through different animal models to verify the 
effect of these gut bacterial against diabetes. An oral 
administration or dietary supplement of Lactobacillus 
were provided in three different mice model. These 
models included diabetes type 2 by using KK-Ay 
mice, mice with type 1 model, and the diabetes mice 
which was induced with Alloxan. The results of all 
these models indicated that the Lactobacillus reduced 
the incidence rate of diabetes and decreased the 
plasma glucose level.95-97 Another model studied the 
effect of Lactobacillus rhamnosus on neonatal mice. 
The study indicated that the neonatal mice who had 
diabetes (induced by streptozotcin) were positively 
affected by taking Lactobacillus rhamnosus. 
Lactobacillus rhamnosus improved the glucose 
tolerance (the serum insulin level increased by the 
first 30 minutes of taking the Lactobacillus).98 
Furthermore, destruction of the pancreatic B-cells 
has been studied by Calcinaro et al., (2005). He 
reported that having a diet containing 
Bifidobacterium and lactobacillus may reduce the B- 
cells destruction among non-obese diabetic mice.99 
Calcinaro et al., (2005) argued that the secretion of 
Interleukin-10 (IL-10) is associated with 
Bifidobacterium and lactobacillus which prevent the 
B-cell’s destruction. Moreover, other studies 
indicated that the oral administration of probiotics 
supplements may control the diabetes risk factors.100 
For example, Yadav et al., (2007), studied the effect of 
feeding probiotics diet that contain Lactobacillus 
acidophilus and L. casei on Fructose-induced diabetes 
mice. The study indicated that the blood glucose level 
and glycosylated hemoglobin free fatty acids and 
triglycerides in the tested mice significantly 
decreased.101  
 
In the relation to the animal study, another paper 
studied the effect of the gut microbiota on mice with 
high fat diet. The studies indicated that the high fat 
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diet led to depletion of the liver’s natural killer T 
(NKT) cells which may lead to the over production of 
pro-inflammatory cytokines. A probiotic supplement 
was given and observed for days. The study reported 
that the gut flora played an important role in 
increasing the number of liver’s natural killer T 
(NKT) cells, and these cells worked against insulin 
resistance, which helped regulate the insulin 
production.102  
 
2.4. Probiotic efficacy in human clinical trials  
It is known that the dietary interventions have been 
used broadly as a primary treatment method against 
diabetes,103 as using the food intervention may be 
useful for managing the diabetes mechanisms 
including but not limited weight, altering 
hyperglycaemia, hyperlipidaemia and insulin 
resistance.104 Limited studies have been done to 
clarify the linkage between the gastrointestinal 
microbiota (probiotics) and chronic diseases in terms 
of dietary supplements intervention.   
 
In the relation to the dietary intervention, limited 
studies indicated that the dietary interventions, 
conjunction with probiotics, as an essential microbial 
supplement40,105 to support the host’s metabolism32 
against Gestational diabetes mellitus (GDM) by 
improving the symptoms of the lactose intolerance 
(106), and as an effective intervention to prevent 
gastrointestinal diseases, such as diarrhea107-8, and via 
targeting all possible risk factors.40   
 
On the other hand, recent advances are aimed 
towards preventive measures in developing GDM 
such as, modification of lifestyle and dietary habits 
that prevent or delay the development of glucose 
intolerance and insulin resistance.109 Gut microbiota 
dysbiosis have been discovered in overweight patients 
with obesity therefore fueling the interest in the role 
of probiotics as a preventive and therapeutic adjunct 
application.32  Studies have started to examine the 
benefits of probiotics in reducing GDM incidence, 
whereby alteration of the host’s metabolism through 
diet could affect microbiota’s composition and gene 
expression.61 
   
The probiotic dietary intervention for pregnant 
women by modulating specific target functions in the 
gut  microbiota  shows  promising  effects beyond the 
obvious nutritional impact of food.32  
 
The  effect  of  the   probiotics treatment is dependent  
on temperature and anaerobic storage conditions, 
initial dose strain and quality (110). As an intervention 
for the prevention of GDM, certain probiotics, as a 
dietary supplement, increase gene expression related 
to fat metabolism and insulin sensitivity, reduces 
inflammatory signalling, and decreases adiposity.111  
 
A few years ago, studies have been done that 
confirmed a correlation between probiotics and 
gestational diabetes mellitus (GDM). Randomized 
controlled trials (RCTs) showed that there is a null or 
positive effect of the probiotics on pregnant women 
who are diagnosed with gestational diabetes mellitus 
(GDM).9  
 
In some human clinical trials, selected probiotics 
showed positive results by decreasing insulin 
resistance syndrome, improved carbohydrate 
metabolism, fasting blood glucose, insulin sensitivity 
and antioxidant status.91  Another randomized 
clinical trial in which a probiotic supplement capsule 
containing four bacterial strains of Lactobacillus 
acidophilus LA-5, Bifidobacterium BB-12, 
Streptococcus Thermophilus STY-31 and 
Lactobacillus delbrueckii bulgaricus LBY-27, 
improved the health condition of pregnant women 
with GDM in relation to inflammation and oxidative 
stress biomarkers.112 This is significant because 
increase in the level of oxidative stress due to 
overproduction of free radicals and a defect in the 
antioxidant defenses are associated with GDM, and 
had implications in the fetal and mother’s well-
being.113 There also was a report in which normal 
weighted pregnant women, through a randomized 
controlled trial, had a combined dietary and probiotic 
supplement intervention, which resulted to a 34% to 
13% decline in the rate of GDM.114 Evidence suggests 
that probiotics have no adverse effects in mother and 
child during pregnancy, and that the daily intake of 
probiotic capsules with Lactobacillus rhamnosus GG 
and Bifidobacterium lactis Bb12 may be effective in 
pregnant women who are at high risk for GDM.115  
 
Despite these advancements in research, it has been 
suggested for future studies that the criteria for GDM 
from the International Association of Diabetes and 
Pregnancy Study Group (116) should be taken into 
account, interventions by specifying subgroups, and 
the    separation  of   patients   with    GDM   early    in  
pregnancy from patients who are newly at risk in 
developing GDM could be an approach that would 
provide the best benefit and result in clinical trials.117  
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